Aly A. Abdelbary
- Pharmaceutical Science top 0.2%
- Molecular Biology
- Dermatology top 2%
- Public Health, Environmental and Occupational Health top 10%
- Biomaterials top 10%
- Co-authors
- Abdulaziz Mohsen Al-mahallawiMohamed H.H. AbouGhalyWessam H. Abd-ElsalamAbdelhalim I. ElassasyMohamed A. El-NabarawiMona Hassan AburahmaRofida AlbashHanan Refai
- Topics
- Advancements in Transdermal Drug Delivery (16 papers)Advanced Drug Delivery Systems (16 papers)Drug Solubulity and Delivery Systems (11 papers)
- Journals
- International Journal of PharmaceuticsInternational Journal of NanomedicineAAPS PharmSciTech
- Partner nations
- EgyptUnited StatesCanada
In The Last Decade
Aly A. Abdelbary
28 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 1.1k
- Molecular Biology 342
- Dermatology 231
- Public Health, Environmental and Occupational Health 193
- Biomaterials 181
Countries citing papers authored by Aly A. Abdelbary
This map shows the geographic impact of Aly A. Abdelbary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly A. Abdelbary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly A. Abdelbary more than expected).
Fields of papers citing papers by Aly A. Abdelbary
This network shows the impact of papers produced by Aly A. Abdelbary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly A. Abdelbary. The network helps show where Aly A. Abdelbary may publish in the future.
Co-authorship network of co-authors of Aly A. Abdelbary
This figure shows the co-authorship network connecting the top 25 collaborators of Aly A. Abdelbary. A scholar is included among the top collaborators of Aly A. Abdelbary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aly A. Abdelbary. Aly A. Abdelbary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 12 | |
| 3 | 51 | |
| 4 | 54 | |
| 5 | 8 | |
| 6 | 63 | |
| 7 | 120 | |
| 8 | 107 | |
| 9 | 6 | |
| 10 | 24 | |
| 11 | 19 | |
| 12 | 163 | |
| 13 | 50 | |
| 14 | 195 | |
| 15 | 237 | |
| 16 | 64 | |
| 17 | 32 | |
| 18 | 10 | |
| 19 | 11 | |
| 20 | Comparative In vivo Evaluation of Aripiprazole Coprecipitate, Nanoparticles and Marketed Tablets in Healthy Human Volunteers and In vitro-In vivo Correlation | 4 |
About Aly A. Abdelbary
Aly A. Abdelbary is a scholar working on Pharmaceutical Science, Dermatology and Gastroenterology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (16 papers), Advanced Drug Delivery Systems (16 papers) and Drug Solubulity and Delivery Systems (11 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Dermatology (231 citations) and Molecular Medicine (73 citations). Aly A. Abdelbary has collaborated with scholars based in Egypt, United States and Canada. Frequent co-authors include Abdulaziz Mohsen Al-mahallawi, Mohamed H.H. AbouGhaly, Wessam H. Abd-Elsalam, Abdelhalim I. Elassasy, Mohamed A. El-Nabarawi, Mona Hassan Aburahma, Rofida Albash, Hanan Refai, Ahmed Hassen Elshafeey and Shaimaa Mosallam. Their work appears in journals such as International Journal of Pharmaceutics, International Journal of Nanomedicine and AAPS PharmSciTech.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.